"
Team:Wageningen UR
From 2012.igem.org
TSlijkhuis (Talk | contribs) |
TSlijkhuis (Talk | contribs) |
||
| Line 24: | Line 24: | ||
<div class="homePO"> | <div class="homePO"> | ||
| - | <img src="https://static.igem.org/mediawiki/2012/b/bf/Po.png" /> | + | <img src="https://static.igem.org/mediawiki/2012/b/bf/Po.png" width="707" height="478" border="0" usemap="#homepo" class="highlight3"/> |
| + | <map name="homepo"> | ||
| + | <area shape="rect" coords="175,6,352,91" alt="Project Introduction" href="/Team:Wageningen_UR/Project" /> | ||
| + | <area shape="rect" coords="367,7,544,92" alt="The Plug 'n Apply System" href="/Team:Wageningen_UR/Coil_system#The_Plug_.27n_Apply_system_.28PnA_system.29" /> | ||
| + | <area shape="rect" coords="447,102,624,188" alt="Virus Like Particles (VLPs)" href="/Team:Wageningen_UR/VLPs#Virus-Like_Particles_.28overview.29" /> | ||
| + | <area shape="rect" coords="526,199,704,284" alt="Outside Modification of VLPs" href="/Team:Wageningen_UR/OutsideModification#Outside_Modification" /> | ||
| + | <area shape="rect" coords="447,295,623,379" alt="Modifications on the inside of VLPs" href="/Team:Wageningen_UR/InsideModification#Inside_Modifications" /> | ||
| + | <area shape="rect" coords="367,391,544,475" alt="How do we detect VLPs?" href="/Team:Wageningen_UR/MethodsDetection#Detection_of_Virus_Like_Particles" /> | ||
| + | <area shape="rect" coords="175,391,352,476" alt="How can we use modified Virus Like Particles?" href="/Team:Wageningen_UR/Applications#Applications" /> | ||
| + | <area shape="rect" coords="87,295,264,379" alt="Modeling of what happens when our VLPs are introduced into the human body." href="/Team:Wageningen_UR/HumanBody#Human_Body_Model" /> | ||
| + | <area shape="rect" coords="7,199,184,283" alt="A short overview of our project." href="/Team:Wageningen_UR/FinalOverview#Final_Overview" /> | ||
| + | </map> | ||
</div> | </div> | ||
Revision as of 15:44, 25 October 2012
Project Overview
A standardized tool for site specific drug delivery using Virus-Like Particles
Medicines are generally active in a non-site-specific fashion, affecting the whole patient, including healthy tissue. Therefore, we attempt to specifically target diseased areas by packaging medicines inside Virus-Like Particles (VLPs). VLPs are not infectious, as they are built solely from viral coat proteins. We designed a modular Plug and Apply system that enables modifications to these coat proteins. The system facilitates the linkage of numerous ligands to the coat protein, thereby creating site-specific carriers. After expression of coat protein genes in Escherichia coli the VLPs were assembled in vitro, yielding modified Virus-Like Particles. Medicines can be packed using the Plug and Apply system or simply by addition during VLP assembly. Concluding, VLPs can be used as universal carriers for site-specific drug delivery, allowing customization to a variety of diseases while decreasing side effects for patients during treatment.
The Team
Europe Jamboree
Gold Medal
Best Presentation
The Constructor
An application that assists you in creating your cloning strategies for your iGEM project.
Human Practices
We ..... ..... ... ... .. .. .. .. .................. .........
